Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated to version v2.13.3, with new additions dated from December 10 to December 12, 2024, while the previous version v2.13.2 and several earlier dates have been removed.
    Difference
    0.5%
    Check dated 2024-12-14T22:38:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information on who to contact for questions about joining the study and where it is taking place, with a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T16:06:58.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Recent additions include three new dates in November 2024, while three earlier dates from September and October 2024 have been removed.
    Difference
    0.5%
    Check dated 2024-11-30T12:54:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Several links to external resources related to viral infections, rare diseases, and clinical studies have been removed, which may impact access to important health information.
    Difference
    3%
    Check dated 2024-11-23T04:36:13.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    New resources have been added, including links to MedlinePlus, NIH, and clinical studies, enhancing access to information on viral infections and rare diseases.
    Difference
    0.4%
    Check dated 2024-11-15T23:38:22.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.
    Difference
    3%
    Check dated 2024-11-08T18:14:13.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.